Cognition Therapeutics In...
(CGTX)
undefined
undefined%
At close: undefined
0.47
-3.66%
Pre-market Dec 16, 2024, 04:20 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 29.92M | 41.56M | 54.72M | 5.19M | 2.89M |
| Short-Term Investments | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - |
| Other Long-Term Assets | - | 1.73M | - | - | - |
| Receivables | 1.28M | 3.67M | 2.27M | 1.15M | 4.12M |
| Inventory | - | - | 1.99M | 544.00K | 117.00K |
| Other Current Assets | 3.02M | 2.41M | 2.00M | 567.00K | 146.00K |
| Total Current Assets | 34.22M | 47.65M | 58.99M | 6.91M | 7.16M |
| Property-Plant & Equipment | 941.00K | 1.05M | 145.00K | 211.00K | 299.00K |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 941.00K | 2.78M | 145.00K | 211.00K | 299.00K |
| Total Assets | 35.16M | 50.42M | 59.14M | 7.12M | 7.46M |
| Account Payables | 3.69M | 3.22M | 4.17M | 2.00M | 2.36M |
| Deferred Revenue | 1.70M | 1.70M | 753.00K | - | 1.32M |
| Short-Term Debt | 348.00K | 298.00K | - | - | 4.00K |
| Other Current Liabilities | 4.42M | 2.58M | 3.70M | 1.25M | 1.32M |
| Total Current Liabilities | 10.17M | 7.79M | 7.86M | 3.25M | 3.68M |
| Long-Term Debt | 1.04M | 1.39M | - | 12.85M | 6.90M |
| Other Long-Term Liabilities | -520.00K | -695.00K | - | 59.20M | 55.30M |
| Total Long-Term Liabilities | 520.00K | 2.38M | - | 72.05M | 62.20M |
| Total Liabilities | 10.69M | 10.18M | 7.86M | 75.30M | 65.88M |
| Total Debt | 1.24M | 1.48M | - | 12.85M | 6.90M |
| Common Stock | 32.00K | 29.00K | 22.00K | 1K | 1K |
| Retained Earnings | -141.19M | -115.40M | -94.00M | -68.22M | -58.24M |
| Comprehensive Income | -195.00K | -199.00K | -198.00K | -187.00K | -185.00K |
| Shareholders Equity | 24.47M | 40.25M | 51.27M | -68.18M | -58.42M |
| Total Investments | - | - | - | - | - |